The cost of dementia exceeded $1 trillion dollars worldwide in 2018 and is expected to double that to $2 trillion dollars in 2030. We are working around the clock to make a huge dent to those figures with our supplements and medicine.
www.mediforum.co
#
Aducanumab, the latest drug approved by the FDA for the treatment of Alzheimer'sis estimated to cost $56,000 annually. According to the New York Times, "There’s little evidence that the drug, Aduhelm, slows the progression of dementia, but the Food and Dr
Brain One is a naturally derived supplement made from a combination of extracts to improve memory %26 concentration. Combining the natural compounds with four-year-aged Korean ginseng boosts the immune system, enhances platelet count, and increases blood
